Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History KALA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics KALA

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Kala Pharmaceuticals Inc

KALA
Current price
5.28 USD +0.12 USD (+2.33%)
Last closed 5.10 USD
ISIN US4831192020
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 32 907 240 USD
Yield for 12 month -22.47 %
1Y
3Y
5Y
10Y
15Y
KALA
21.11.2021 - 28.11.2021

KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts. Address: 1167 Massachusetts Avenue, Arlington, MA, United States, 02476

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

13.50 USD

P/E Ratio

Dividend Yield

Financials KALA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures KALA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-303 000 USD

Current Quarter

Last Quarter

EBITDA -39 048 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -48.51 %
PEG Ratio
Return On Equity TTM -576.46 %
Wall Street Target Price 13.50 USD
Revenue TTM
Book Value 0.89 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100.00 %
Dividend Yield
Gross Profit TTM 1 332 000 USD
Earnings per share -7.36 USD
Diluted Eps TTM -7.36 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation KALA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.042
Price Sales TTM 1.16
Enterprise Value EBITDA -0.16
Price Book MRQ 5.77

Technical Indicators KALA

For 52 Weeks

2.92 USD 11.20 USD
50 Day MA 3.99 USD
Shares Short Prior Month 294 009
200 Day MA 5.88 USD
Short Ratio 6.61
Shares Short 296 392
Short Percent 5.85 %